{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T09:48:53Z","timestamp":1659001733611},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,6,7]],"date-time":"2008-06-07T00:00:00Z","timestamp":1212796800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00105-008-1498-y","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T11:24:57Z","timestamp":1212665097000},"page":"579-590","source":"Crossref","is-referenced-by-count":2,"title":["Medikament\u00f6se Therapie der Akne"],"prefix":"10.1007","volume":"59","author":[{"given":"F.R.","family":"Ochsendorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Degitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,7]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00128071-200304070-00004","volume":"4","author":"Akhavan","year":"2003","unstructured":"Akhavan A, Bershad S (2003) Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 4: 473\u2013492","journal-title":"Am J Clin Dermatol"},{"key":"1498_CR2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00403-007-0777-2","volume":"299","author":"Akman","year":"2007","unstructured":"Akman A, Durusoy C, Senturk M et al. (2007) Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res 299: 467\u2013473","journal-title":"Arch Dermatol Res"},{"key":"1498_CR3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","volume":"46","author":"Archer","year":"2002","unstructured":"Archer JS, Archer DF (2002) Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 46: 917\u2013923","journal-title":"J Am Acad Dermatol"},{"key":"1498_CR4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1529-8019.2006.00078.x","volume":"19","author":"Baldwin","year":"2006","unstructured":"Baldwin HE (2006) Tricks for improving compliance with acne therapy. Dermatol Ther 19: 224\u2013236","journal-title":"Dermatol Ther"},{"key":"1498_CR5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2125.2006.02837.x","volume":"63","author":"Berard","year":"2007","unstructured":"Berard A, Azoulay L, Koren G et al. (2007) Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol 63: 196\u2013205","journal-title":"Br J Clin Pharmacol"},{"key":"1498_CR6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00105-005-1036-0","volume":"56","author":"Borelli","year":"2005","unstructured":"Borelli C, Merk K, Plewig G, Degitz K (2005) Licht, Laser und PDT-Therapie bei Akne. Hautarzt 56: 1027\u20131032","journal-title":"Hautarzt"},{"key":"1498_CR7","first-page":"5","volume":"78","author":"Campbell","year":"2006","unstructured":"Campbell JL Jr, Weiss JS (2006) The results of the MORE trial: overview. Cutis 78: 5\u201311","journal-title":"Cutis"},{"key":"1498_CR8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1046\/j.1365-2133.2003.05369.x","volume":"148","author":"Degitz","year":"2003","unstructured":"Degitz K, Placzek M, Arnold B et al. (2003) Congenital adrenal hyperplasia and acne in male patients. Br J Dermatol 148: 1263\u20131266","journal-title":"Br J Dermatol"},{"key":"1498_CR9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1610-0387.2007.06274.x","volume":"5","author":"Degitz","year":"2007","unstructured":"Degitz K, Placzek M, Borelli C, Plewig G (2007) Pathophysiologie der Akne. J Dtsch Dermatol Ges 5: 316\u2013323","journal-title":"J Dtsch Dermatol Ges"},{"key":"1498_CR10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1610-0378.2005.04087.x","volume":"3","author":"Degitz","year":"2005","unstructured":"Degitz K, Plewig G (2005) Erg\u00e4nzende Verfahren in der Aknetherapie. J Dtsch Dermatol Ges 3: 92\u201396","journal-title":"J Dtsch Dermatol Ges"},{"key":"1498_CR11","first-page":"391","volume":"14","author":"Dreno","year":"2004","unstructured":"Dreno B, Bettoli V, Ochsendorf F et al. (2004) European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 14: 391\u2013399","journal-title":"Eur J Dermatol"},{"key":"1498_CR12","doi-asserted-by":"crossref","unstructured":"Garner SE, Eady EA, Popescu C et al. (2002) Minocycline for acne vulgaris: efficacy and safety (Cochrane Review). The Cochrane Library. Oxford: Update Software","DOI":"10.1002\/14651858.CD002086"},{"key":"1498_CR13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"Gollnick","year":"2003","unstructured":"Gollnick HP, Cunliffe WJ (2003) Management of acne. A report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 49: S1\u2013S38","journal-title":"J Am Acad Dermatol"},{"key":"1498_CR14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1439-0353.2004.04731.x","volume":"2","author":"Gollnick","year":"2004","unstructured":"Gollnick HP, Graupe K, Zaumseil RP (2004) Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges 2: 841\u2013847","journal-title":"J Dtsch Dermatol Ges"},{"key":"1498_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000067820","volume":"206","author":"Gollnick","year":"2003","unstructured":"Gollnick HP, Krautheim A (2003) Topical treatment in acne: current status and future aspects. Dermatology 206: 29\u201336","journal-title":"Dermatology"},{"key":"1498_CR16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jama.292.6.726","volume":"292","author":"Haider","year":"2004","unstructured":"Haider A, Shaw JC (2004) Treatment of acne vulgaris. Jama 292: 726\u2013735","journal-title":"Jama"},{"key":"1498_CR17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2710.2007.00853.x","volume":"32","author":"Heaton","year":"2007","unstructured":"Heaton PC, Fenwick SR, Brewer DE (2007) Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study. J Clin Pharm Ther 32: 483\u2013487","journal-title":"J Clin Pharm Ther"},{"key":"1498_CR18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001050170015","volume":"52","author":"Hofer","year":"2001","unstructured":"Hofer T, Itin PH (2001) Acne inversa: a dapsone-sensitive dermatosis. Hautarzt 52: 989\u2013992","journal-title":"Hautarzt"},{"key":"1498_CR19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1468-3083.2006.01907.x","volume":"21","author":"Jones-Caballero","year":"2007","unstructured":"Jones-Caballero M, Chren MM, Soler B et al. (2007) Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatol Venereol 21: 219\u2013226","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1498_CR20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2006.01671.x","volume":"20","author":"Layton","year":"2006","unstructured":"Layton AM, Dreno B, Gollnick HP, Zouboulis CC (2006) A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol 20: 773\u2013776","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1498_CR21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archderm.142.5.605","volume":"142","author":"Leyden","year":"2006","unstructured":"Leyden J, Thiboutot DM, Shalita AR et al. (2006) Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 142: 605\u2013612","journal-title":"Arch Dermatol"},{"key":"1498_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2005.04.046","volume":"54","author":"Leyden","year":"2006","unstructured":"Leyden JJ, Krochmal L, Yaroshinsky A (2006) Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin\/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. J Am Acad Dermatol 54: 73\u201381","journal-title":"J Am Acad Dermatol"},{"key":"1498_CR23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archderm.141.9.1132","volume":"141","author":"Margolis","year":"2005","unstructured":"Margolis DJ, Bowe WP, Hoffstad O, Berlin JA (2005) Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 141: 1132\u20131136","journal-title":"Arch Dermatol"},{"key":"1498_CR24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2133.2007.08056.x","volume":"157","author":"Margolis","year":"2007","unstructured":"Margolis DJ, Hoffstad O, Bilker W (2007) Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol 157: 540\u2013546","journal-title":"Br J Dermatol"},{"key":"1498_CR25","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/sj.jid.5700289","volume":"126","author":"Nelson","year":"2006","unstructured":"Nelson AM, Gilliland KL, Cong Z, Thiboutot DM (2006) 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol 126: 2178\u20132189","journal-title":"J Invest Dermatol"},{"key":"1498_CR26","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1610-0387.2006.06053.x","volume":"4","author":"Ochsendorf","year":"2006","unstructured":"Ochsendorf F (2006) Systemische Antibiotikatherapie der Akne. J Dtsch Dermatol Ges 4: 828\u2013841","journal-title":"J Dtsch Dermatol Ges"},{"key":"1498_CR27","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta9010","volume":"9","author":"Ozolins","year":"2005","unstructured":"Ozolins M, Eady EA, Avery A et al. (2005) Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technol Assess 9: iii-212","journal-title":"Health Technol Assess"},{"key":"1498_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.06614.x","volume":"153","author":"Simonart","year":"2005","unstructured":"Simonart T, Dramaix M (2005) Treatment of acne with topical antibiotics: lessons from clinical studies. Br J Dermatol 153: 395\u2013403","journal-title":"Br J Dermatol"},{"key":"1498_CR29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","volume":"139","author":"Skidmore","year":"2003","unstructured":"Skidmore R, Kovach R, Walker C et al. (2003) Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 139: 459\u2013464","journal-title":"Arch Dermatol"},{"key":"1498_CR30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-4632.2006.02660.x","volume":"45","author":"Strahan","year":"2006","unstructured":"Strahan JE, Raimer S (2006) Isotretinoin and the controversy of psychiatric adverse effects. Int J Dermatol 45: 789\u2013799","journal-title":"Int J Dermatol"},{"key":"1498_CR31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","volume":"10","author":"Strauss","year":"1984","unstructured":"Strauss JS, Rapini RP, Shalita AR et al. (1984) Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 10: 490\u2013496","journal-title":"J Am Acad Dermatol"},{"key":"1498_CR32","first-page":"256","volume":"5","author":"Tanghetti","year":"2006","unstructured":"Tanghetti E, Abramovits W, Solomon B et al. (2006) Tazarotene versus tazarotene plus clindamycin\/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. J Drugs Dermatol 5: 256\u2013261","journal-title":"J Drugs Dermatol"},{"key":"1498_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","volume":"206","author":"Thiboutot","year":"2003","unstructured":"Thiboutot D, Chen W (2003) Update and future of hormonal therapy in acne. Dermatology 206: 57\u201367","journal-title":"Dermatology"},{"key":"1498_CR34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1540-9740.2005.04279.x","volume":"4","author":"Thiboutot","year":"2005","unstructured":"Thiboutot DM, Shalita AR, Yamauchi PS et al. (2005) Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. Skinmed 4: 138\u2013146","journal-title":"Skinmed"},{"key":"1498_CR35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archderm.142.5.597","volume":"142","author":"Thiboutot","year":"2006","unstructured":"Thiboutot DM, Shalita AR, Yamauchi PS et al. (2006) Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 142: 597\u2013602","journal-title":"Arch Dermatol"},{"key":"1498_CR36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2007.06.006","volume":"57","author":"Thiboutot","year":"2007","unstructured":"Thiboutot DM, Weiss J, Bucko A et al. (2007) Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol 57: 791\u2013799","journal-title":"J Am Acad Dermatol"},{"key":"1498_CR37","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00105-005-1039-x","volume":"56","author":"Thielitz","year":"2005","unstructured":"Thielitz A, Gollnick H (2005) Systemische Aknetherapie. Hautarzt 56: 1040\u20131047","journal-title":"Hautarzt"},{"key":"1498_CR38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1365-2133.2005.06357.x","volume":"152","author":"Zaghloul","year":"2005","unstructured":"Zaghloul SS, Cunliffe WJ, Goodfield MJ (2005) Objective assessment of compliance with treatments in acne. Br J Dermatol 152: 1015\u20131021","journal-title":"Br J Dermatol"},{"key":"1498_CR39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1610-0387.2003.03011.x","volume":"1","author":"Zouboulis","year":"2003","unstructured":"Zouboulis CC (2003) Treatment of acne with antiandrogens \u2013 an evidence-based review. JDDG 1: 535\u2013546","journal-title":"JDDG"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1498-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-008-1498-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1498-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:37:37Z","timestamp":1558568257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-008-1498-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1007\/s00105-008-1498-y","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,7]]}}}